XmAb24306

The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Tue, 02/5/19 - 10:05 am
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies